MUMBAI: Japanese drugmaker Daaichi Sankyo Company has completed the acquisition of Ranbaxy Laboratories, with the final transfer of the promoters’ stake. As a result of this acquisition of shares, the Singh family has ceased to be the promoters of the co mpany and Daiichi Sankyo has become the promoter of the company with effect from November 7.
Daiichi now holds 63.92 per cent stake in Ranbaxy, the companies said in a statement to the Bombay Stock Exchange on Friday.
No comments:
Post a Comment